MDCX 424B3: Material agreement

Filed with the SEC on · accession 0001062993-26-006045

MDCX filed a 424B3 (prospectus (offering)) with the SEC on Nov 16, 2026. Medicus Pharma Ltd. exchanged $10.5 million of principal under its Secured Promissory Note A-1 for 105,000 non-convertible, non-voting preferred shares at $100 per share, reducing its outstanding debt. The stock moved +0.5% by the first close after the filing.

Summary of the filing

Medicus Pharma Ltd. exchanged $10.5 million of principal under its Secured Promissory Note A-1 for 105,000 non-convertible, non-voting preferred shares at $100 per share, reducing its outstanding debt. The preferred shares carry an 8% cumulative dividend payable in kind and are redeemable at the company's option.

Key details

Principal amount of A-1 Note exchanged$10.5M
Number of preferred shares issued$105K
Issue price per preferred share$100
Remaining principal and accrued interest under A Notes$4.2M
Outstanding under Secured Promissory Note B$8.2M
IssuerMedicus Pharma Ltd.
Investor/counterpartyStreeterville Capital, LLC

How MDCX stock reacted

Close before

$1.95

Nov 13, 2026

First close after

+0.51%

$1.96

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for MDCX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MDCX?

Click here

Frequently asked questions

What did MDCX file with the SEC on Nov 16, 2026?

MDCX filed a 424B3 (Material agreement). Medicus Pharma Ltd. exchanged $10.5 million of principal under its Secured Promissory Note A-1 for 105,000 non-convertible, non-voting preferred shares at $100 per share, reducing its outstanding debt. The preferred shares carry an 8% cumulative dividend payable in kind and are redeemable at the company's option.

What does a material agreement mean for MDCX stock?

A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.

How do I read a 424B3?

The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.

How did MDCX stock react to this filing?

MDCX closed at $1.95 before the filing and $1.96 on Nov 16, 2026 (+0.51%).

Other MDCX SEC filings

Get alerts when MDCX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days